The role of interleukin-15 in the development and treatment of hematological malignancies.
IL-15
blood
cancer
cytokine
treatment
Journal
Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960
Informations de publication
Date de publication:
2023
2023
Historique:
received:
10
01
2023
accepted:
22
02
2023
medline:
9
5
2023
pubmed:
8
5
2023
entrez:
8
5
2023
Statut:
epublish
Résumé
Cytokines are a vital component of the immune system that controls the activation and growth of blood cells. However, chronic overexpression of cytokines can trigger cellular events leading to malignant transformation. The cytokine interleukin-15 (IL-15) is of particular interest, which has been shown to contribute to the development and progression of various hematological malignancies. This review will provide an overview of the impact of the immunopathogenic function of IL-15 by studying its role in cell survival, proliferation, inflammation, and treatment resistance. We will also review therapeutic approaches for inhibiting IL-15 in blood cancers.
Identifiants
pubmed: 37153603
doi: 10.3389/fimmu.2023.1141208
pmc: PMC10157481
doi:
Substances chimiques
Cytokines
0
Interleukin-15
0
IL15 protein, human
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1141208Informations de copyright
Copyright © 2023 Sindaco, Pandey, Isabelle, Chakravarti, Brammer, Porcu and Mishra.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Blood. 1996 Apr 15;87(8):3327-35
pubmed: 8605349
Biotechnol Prog. 2012 Mar-Apr;28(2):497-507
pubmed: 22162520
Blood. 1998 Jul 1;92(1):252-8
pubmed: 9639524
Exp Hematol. 2011 Nov;39(11):1064-71
pubmed: 21864486
Proc Natl Acad Sci U S A. 2009 Sep 15;106(37):15849-54
pubmed: 19805228
Leuk Lymphoma. 2015 Jan;56(1):151-6
pubmed: 24689757
Proc Natl Acad Sci U S A. 2022 Jan 18;119(3):
pubmed: 35027451
Blood Adv. 2019 Mar 26;3(6):897-907
pubmed: 30890546
Science. 1994 May 13;264(5161):965-8
pubmed: 8178155
J Immunol. 2001 Feb 15;166(4):2602-9
pubmed: 11160322
Front Immunol. 2021 Dec 17;12:730970
pubmed: 34975835
Nat Immunol. 2019 Jan;20(1):10-17
pubmed: 30538328
J Immunol. 2004 Dec 1;173(11):6676-83
pubmed: 15557159
Oncotarget. 2017 Jul 4;8(27):44366-44378
pubmed: 28574833
Front Immunol. 2020 May 19;11:868
pubmed: 32508818
Clin Cancer Res. 2010 Dec 15;16(24):6019-28
pubmed: 20924130
J Immunother Cancer. 2021 May;9(5):
pubmed: 34001523
Lancet Oncol. 2018 May;19(5):694-704
pubmed: 29628312
Blood. 2011 May 5;117(18):4787-95
pubmed: 21385847
Leukemia. 2012 Jan;26(1):139-48
pubmed: 21788945
Exp Dermatol. 2000 Aug;9(4):248-51
pubmed: 10949545
Cancer Immunol Immunother. 2021 May;70(5):1305-1321
pubmed: 33140189
Nat Commun. 2021 Jul 13;12(1):4290
pubmed: 34257288
J Clin Oncol. 2011 Apr 1;29(10):1356-63
pubmed: 21300928
J Invest Dermatol. 2001 Sep;117(3):583-9
pubmed: 11564163
J Clin Oncol. 2007 Oct 20;25(30):4813-20
pubmed: 17947730
Cancer Res. 2008 Feb 15;68(4):1083-91
pubmed: 18281483
J Clin Oncol. 2015 Jan 1;33(1):74-82
pubmed: 25403209
Br J Haematol. 2002 Nov;119(2):467-74
pubmed: 12406087
J Clin Pharmacol. 2020 Feb;60(2):264-273
pubmed: 31465127
Blood Adv. 2022 Nov 04;:
pubmed: 36332004
J Immunol. 2004 Aug 1;173(3):1681-8
pubmed: 15265897
Pediatr Hematol Oncol. 2018 Feb;35(1):37-44
pubmed: 29528261
Clin Cancer Res. 2016 Jul 15;22(14):3440-50
pubmed: 26847056
Br J Dermatol. 2001 May;144(5):1016-23
pubmed: 11359391
Glycoconj J. 2016 Jun;33(3):417-33
pubmed: 26563299
Leuk Res. 2010 Feb;34(2):203-9
pubmed: 19660811
J Immunol Res. 2014;2014:149185
pubmed: 24901008
J Exp Med. 2020 Jan 6;217(1):
pubmed: 31821442
EMBO J. 1994 Jun 15;13(12):2822-30
pubmed: 8026467
Leukemia. 2012 Apr;26(4):693-9
pubmed: 21912394
Proc Natl Acad Sci U S A. 2020 Jan 7;117(1):522-531
pubmed: 31871169
J Invest Dermatol. 2007 Nov;127(11):2544-51
pubmed: 17554368
J Transl Med. 2022 Sep 27;20(1):432
pubmed: 36167591
J Cancer Res Clin Oncol. 2018 Jul;144(7):1279-1288
pubmed: 29737430
Proc Natl Acad Sci U S A. 2006 Jan 10;103(2):401-6
pubmed: 16387851
J Clin Invest. 2010 Jun;120(6):2131-43
pubmed: 20440074
Cancer. 2010 Jan 15;116(2):387-92
pubmed: 19924795
PLoS One. 2010 Oct 25;5(10):e13626
pubmed: 21049047
Blood. 1997 Jan 1;89(1):201-11
pubmed: 8978293
Int J Biol Sci. 2011;7(5):651-8
pubmed: 21647333
Blood Adv. 2019 Jul 9;3(13):1970-1980
pubmed: 31266741
J Biol Chem. 2015 Sep 11;290(37):22338-51
pubmed: 26183780
J Biol Chem. 2016 Nov 11;291(46):23869-23881
pubmed: 27650494
Front Immunol. 2022 Sep 12;13:997482
pubmed: 36172388
Leukemia. 2015 May;29(5):1213-8
pubmed: 25486870
Leukemia. 2019 May;33(5):1243-1255
pubmed: 30353031
Cytokine. 2001 Jan 7;13(1):39-50
pubmed: 11145841
Future Oncol. 2021 Sep;17(27):3549-3560
pubmed: 34154392
Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10915-E10924
pubmed: 30373815
N Engl J Med. 2020 Feb 6;382(6):545-553
pubmed: 32023374
Blood. 2011 Dec 22;118(26):6845-8
pubmed: 22067383
Med Oncol. 2015 Jan;32(1):370
pubmed: 25428383
Front Immunol. 2021 Mar 18;12:610789
pubmed: 33815365
Blood. 2001 Jan 1;97(1):14-32
pubmed: 11133738
Cancer Res. 2009 May 1;69(9):3986-94
pubmed: 19366803
Cancer Immunol Res. 2020 Sep;8(9):1139-1149
pubmed: 32661096
Sci Rep. 2017 Dec 8;7(1):17230
pubmed: 29222435
J Immunol. 2022 Mar 15;208(6):1362-1370
pubmed: 35228263
JCI Insight. 2018 Feb 8;3(3):
pubmed: 29415897
Immunity. 2015 May 19;42(5):826-38
pubmed: 25992859
Cancer Cell. 2012 Nov 13;22(5):645-55
pubmed: 23153537
Blood Adv. 2023 Feb 14;7(3):384-394
pubmed: 35475910
Oncoimmunology. 2018 Nov 27;8(2):e1532764
pubmed: 30713787
J Immunol. 2013 Oct 1;191(7):3634-40
pubmed: 23997218
Mol Ther. 2021 Dec 1;29(12):3410-3421
pubmed: 34174441
J Immunol. 2008 Feb 15;180(4):2099-106
pubmed: 18250415
Cytokine Growth Factor Rev. 2002 Dec;13(6):429-39
pubmed: 12401478
Proc Natl Acad Sci U S A. 1998 Mar 3;95(5):2452-7
pubmed: 9482906
Front Immunol. 2021 Jan 18;11:594620
pubmed: 33537030
Blood. 2008 Feb 15;111(4):2181-9
pubmed: 18025151
J Immunother Cancer. 2021 Dec;9(12):
pubmed: 34896980
Blood. 2011 Feb 10;117(6):1938-46
pubmed: 21106989
Clin Exp Immunol. 2006 Dec;146(3):559-66
pubmed: 17100778
Gastroenterology. 2003 Sep;125(3):730-45
pubmed: 12949719
Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):13897-902
pubmed: 9391124
Nat Rev Cancer. 2004 Jan;4(1):11-22
pubmed: 14708024
Br J Haematol. 1999 Jul;106(1):28-34
pubmed: 10444159
J Hematol Oncol. 2016 Sep 29;9(1):101
pubmed: 27686372
J Exp Med. 2004 Oct 4;200(7):825-34
pubmed: 15452177
Blood Adv. 2023 Jan 10;7(1):9-19
pubmed: 35882498
J Immunol. 2019 May 15;202(10):2924-2944
pubmed: 30988120
J Immunother Cancer. 2020 Nov;8(2):
pubmed: 33203664
J Biol Chem. 2006 Jan 20;281(3):1612-9
pubmed: 16284400
J Exp Med. 2022 Dec 5;219(12):
pubmed: 36165896
J Exp Med. 2001 Jan 15;193(2):219-31
pubmed: 11208862
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11445-50
pubmed: 11016962
J Immunother Cancer. 2021 Apr;9(4):
pubmed: 33883258
J Exp Med. 2000 Mar 6;191(5):771-80
pubmed: 10704459
Proc Natl Acad Sci U S A. 1994 May 24;91(11):4935-9
pubmed: 8197160
J Immunol. 2009 Sep 15;183(6):3598-607
pubmed: 19710453
Blood. 2005 Oct 1;106(7):2302-10
pubmed: 15976182
Blood. 2018 Jun 7;131(23):2515-2527
pubmed: 29463563
J Immunother Cancer. 2021 Nov;9(11):
pubmed: 34799399
Proc Natl Acad Sci U S A. 2016 Nov 29;113(48):E7788-E7797
pubmed: 27849617
Cancer Res. 2013 May 15;73(10):3075-86
pubmed: 23644531
Mol Pharm. 2020 Sep 8;17(9):3378-3391
pubmed: 32787272
Blood. 2008 Jan 15;111(2):517-24
pubmed: 17938255
Cytokine. 2007 Feb;37(2):171-5
pubmed: 17446083
Oncotarget. 2016 May 10;7(19):27479-88
pubmed: 27036031
Proc Natl Acad Sci U S A. 1996 Apr 2;93(7):2897-902
pubmed: 8610139
Blood. 2000 Jan 15;95(2):610-8
pubmed: 10627470
J Exp Med. 2009 Jan 16;206(1):25-34
pubmed: 19103877
Eur J Immunol. 2014 Aug;44(8):2500-7
pubmed: 24825007
J Biol Chem. 2013 Jun 21;288(25):18093-103
pubmed: 23649624
Blood. 2014 May 15;123(20):3116-27
pubmed: 24700781
Int J Cancer. 1998 Oct 5;78(2):189-95
pubmed: 9754651
Clin Cancer Res. 2016 Feb 1;22(3):596-608
pubmed: 26423796
Blood. 2012 Jan 5;119(1):137-43
pubmed: 22049515
Proc Natl Acad Sci U S A. 2019 Jan 8;116(2):599-608
pubmed: 30587590
Clin Cancer Res. 2017 Jun 1;23(11):2817-2830
pubmed: 27986749
J Immunother Cancer. 2022 Jan;10(1):
pubmed: 35101947
Blood. 2012 Jul 5;120(1):e1-8
pubmed: 22496150
J Clin Oncol. 2017 Jun 1;35(16):1803-1813
pubmed: 28291388
Blood. 2022 Feb 24;139(8):1177-1183
pubmed: 34797911
J Immunol. 1998 May 1;160(9):4418-26
pubmed: 9574546
Br J Cancer. 2014 Mar 18;110(6):1673-80
pubmed: 24434428
Blood. 2013 Jan 17;121(3):476-84
pubmed: 23212516
Blood. 2015 May 28;125(22):3420-31
pubmed: 25896649
J Immunol. 2015 Aug 1;195(3):901-23
pubmed: 26136429
SAGE Open Med. 2020 Oct 20;8:2050312120965752
pubmed: 33194199
J Clin Invest. 2021 Oct 1;131(19):
pubmed: 34375310
Int J Cancer. 2012 Jan 1;130(1):48-58
pubmed: 21618217
JAMA. 2009 Jan 28;301(4):393-403
pubmed: 19176441
Cancer Discov. 2016 Sep;6(9):986-1005
pubmed: 27422033
Clin Cancer Res. 2021 Jun 15;27(12):3339-3350
pubmed: 33832946
Leukemia. 2016 Aug;30(8):1749-52
pubmed: 26876593
Mol Cancer Ther. 2021 Feb;20(2):347-356
pubmed: 33293344
Front Immunol. 2018 Jul 11;9:1603
pubmed: 30050538
Blood Adv. 2018 Nov 27;2(22):3177-3192
pubmed: 30482760
J Interferon Cytokine Res. 2019 Jan;39(1):6-21
pubmed: 29889594
J Clin Immunol. 2011 Dec;31(6):1038-44
pubmed: 21938511